PMID: 9161645May 1, 1997Paper

Reliability of a modified medication appropriateness index in ambulatory older persons

The Annals of Pharmacotherapy
L S FitzgeraldM E Williams

Abstract

To evaluate the reliability of a medication appropriateness index (MAI) modified for elderly outpatients in a non-Veterans Affairs setting. Reliability study. General community. Ten community-dwelling elderly (> 65 y) taking five or more regularly scheduled medications and participating in a university-based health service intervention study. Interrater reliability of MAI ratings of 65 medications made by two clinical pharmacists for individual items and for an overall summed score was calculated by use of kappa statistics and intraclass correlation coefficient. The interrater agreement for each of the individual MAI items was high for both appropriate and inappropriate ratings and ranged from 80% to 100% (overall kappa = 0.64). Overall agreement for the summed score was good (intraclass correlation = 0.80). The modified MAI is a reliable instrument for evaluation of medication appropriateness in a non-Veterans Affairs, ambulatory, elderly population and may provide pharmacists with a practical and standard method to evaluate patients' drug regimens and identify some potential drug-related problems.

References

Oct 15, 1992·Annals of Internal Medicine·M H BeersJ C Beck
Oct 1, 1992·Journal of Clinical Epidemiology·J T HanlonJ R Feussner
Nov 1, 1991·Clinical Pharmacology and Therapeutics·H L Lipton, J A Bird
Jan 1, 1990·Journal of Clinical Epidemiology·D V Cicchetti, A R Feinstein
Oct 1, 1985·Drug Intelligence & Clinical Pharmacy·L A ShimpB F Atwood
Nov 1, 1994·The Annals of Pharmacotherapy·B R Canaday, P C Yarborough
Dec 1, 1994·Journal of the American Geriatrics Society·K SchmaderJ R Feussner
May 1, 1997·The Annals of Pharmacotherapy·P S SheltonM Weinberger

❮ Previous
Next ❯

Citations

Oct 18, 2005·Pharmacy World & Science : PWS·Mary P Tully, Judith A Cantrill
Feb 7, 2007·Medical Care·Michael A SteinmanPeter J Kaboli
Jun 10, 2009·Journal of the American Geriatrics Society·Elizabeth A ChrischillesRobert B Wallace
Apr 5, 2013·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Brian C LundPeter J Kaboli
Jun 7, 2013·Drugs & Aging·E Jennifer EdelmanAmy C Justice
Oct 1, 2010·Therapeutic Advances in Drug Safety·Nicholas M WilsonSarah N Hilmer
Sep 3, 2005·Journal of the American Geriatrics Society·Emily R HajjarKenneth E Schmader
Oct 4, 2005·European Journal of Clinical Pharmacology·Lisbeth BregnhøjJesper Sonne
Oct 14, 2006·Journal of the American Geriatrics Society·Michael A SteinmanPeter J Kaboli
May 28, 2009·The Annals of Pharmacotherapy·Ronald L CastelinoTimothy F Chen
Jan 18, 2008·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Kevin T Bain, Douglas J Weschules
Jul 30, 2008·Blood Pressure·Talma Rosenthal, Naomi Nussinovitch
Mar 27, 2012·PM & R : the Journal of Injury, Function, and Rehabilitation·Andrew I GellerDale C Strasser
Sep 4, 2015·Journal of the American Medical Informatics Association : JAMIA·Hojjat SalmasianCarol Friedman
Feb 24, 2001·Journal of the American Geriatrics Society·J T HanlonM Weinberger
Nov 25, 2005·European Journal of Clinical Pharmacology·Laurent AzoulayAnick Bérard
Mar 14, 2007·Pharmacy World & Science : PWS·Lisbeth BregnhøjJesper Sonne
Sep 16, 2010·British Journal of Clinical Pharmacology·Norul Badriah HassanAbdul Rashid Abdul Rahman
Jan 6, 2018·Current Medical Research and Opinion·Linda Ghali KoriaRonald Castelino
Mar 28, 2019·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Sharmin S BalaPrasad S Nishtala
Feb 17, 2000·The Annals of Pharmacotherapy·P R WardP R Noyce
Jun 22, 2000·The Annals of Pharmacotherapy·B L Carter, D K Helling
Apr 18, 2008·AACN Advanced Critical Care·Catherine G Ferrario
May 31, 2012·Drugs & Aging·Marie N O'ConnorDenis O'Mahony
Apr 27, 2010·The Oncologist·Ronald J MaggioreArti Hurria
Dec 23, 2019·European Journal of Clinical Pharmacology·José-Ramón BlancoUNKNOWN Gesida and SEFH
May 12, 2006·Journal of the American Geriatrics Society·Anne SpinewineChristian Swine
Mar 13, 2009·Pharmacy World & Science : PWS·Clementine C M StuijtStephen A Hudson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.